Key Insights
The France self-monitoring blood glucose (SMBG) devices market, valued at €532 million in 2025, is projected to experience robust growth, driven by the increasing prevalence of diabetes and the rising adoption of advanced SMBG technologies. The market's Compound Annual Growth Rate (CAGR) of 7.18% from 2025 to 2033 indicates a significant expansion, fueled by factors such as growing awareness about diabetes management, an aging population susceptible to diabetes, and increasing healthcare expenditure in France. Technological advancements, including the development of more accurate, user-friendly, and connected devices, further contribute to market growth. However, the market faces restraints such as high costs associated with devices and consumables, and the potential for reimbursement challenges. The market is segmented into Glucometer Devices, Test Strips, and Lancets, with Glucometer Devices likely holding the largest market share due to their critical role in diabetes management. Key players like Roche Diabetes Care, Abbott Diabetes Care, and LifeScan are driving innovation and competition within the market, focusing on product diversification and strategic partnerships. The historical period (2019-2024) likely witnessed similar growth trends, although at a potentially slightly lower CAGR, reflecting a maturing market before the acceleration projected for the forecast period (2025-2033).
The competitive landscape is characterized by both established multinational corporations and smaller specialized companies. These companies are constantly engaged in strategies to enhance market share through product innovation, improved distribution networks, and targeted marketing campaigns focused on patient education and engagement. Future growth will likely be influenced by the success of continuous glucose monitoring (CGM) systems gaining wider acceptance and reimbursement, the introduction of integrated diabetes management solutions and the increasing adoption of telehealth and remote monitoring technologies for diabetes management in France. The regional focus remains primarily on France, but understanding broader European trends can offer valuable insight into future market dynamics.
France Self-Monitoring Blood Glucose Devices Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the France Self-Monitoring Blood Glucose Devices market, offering invaluable insights for industry professionals, investors, and strategists. Covering the period 2019-2033, with a focus on 2025 (base and estimated year), this report unveils market dynamics, competitive landscapes, and future growth potential. The report segments the market by component (Glucometer Devices, Test Strips, Lancets) and provides granular data on market size, growth rates, and key players.

France Self-Monitoring Blood Glucose Devices Market Market Structure & Innovation Trends
The France Self-Monitoring Blood Glucose Devices market exhibits a moderately concentrated structure, with a few major players holding significant market share. Precise market share data for individual companies is not readily available, but a preliminary competitive landscape analysis suggests an approximate xx% market share held by the top five players. Innovation is driven by the need for improved accuracy, convenience, and integration with digital health platforms. The regulatory framework, primarily governed by [Relevant French Regulatory Body], influences product approvals and market entry. The market also sees the emergence of innovative connected devices which leverage mobile applications to enhance patient self-management and improve treatment adherence. Significant M&A activity is xx Million, primarily focused on strengthening product portfolios and expanding market reach. Market share data for individual companies are not available but the top 5 players hold approximately xx% of the market. The top 5 players are:
- Roche Diabetes Care
- Abbott Diabetes Care
- LifeScan
- Arkray Inc
- Ascensia Diabetes Care

France Self-Monitoring Blood Glucose Devices Market Market Dynamics & Trends
The France Self-Monitoring Blood Glucose Devices market is experiencing steady growth, driven by the rising prevalence of diabetes, increasing healthcare expenditure, and growing adoption of technologically advanced devices. The market is expected to witness a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). This growth is fuelled by increasing awareness regarding the importance of regular blood glucose monitoring among diabetics. Technological advancements such as Bluetooth connectivity, mobile app integration, and continuous glucose monitoring (CGM) systems are transforming the market landscape, enhancing patient convenience and data management capabilities. Consumer preferences are shifting towards compact, user-friendly devices with advanced features and improved accuracy. Competitive dynamics are shaping up with established players focusing on product innovation and new market entrants introducing disruptive technologies. Market penetration for self-monitoring blood glucose devices is estimated to be at xx% in France in 2025.

Dominant Regions & Segments in France Self-Monitoring Blood Glucose Devices Market
The dominant segment within the France Self-Monitoring Blood Glucose Devices market is Test Strips, accounting for the largest market share due to their frequent usage in conjunction with glucometers.
- Key Drivers for Test Strips Dominance:
- High consumption rate due to frequent blood glucose monitoring needs.
- Relatively lower cost compared to glucometers.
- Ongoing requirement for replacement, ensuring consistent demand.
- Continuous innovation in strip technology improving accuracy and ease-of-use.
The Glucometer Devices segment holds a significant share, driven by the increasing adoption of advanced features such as connectivity, data logging, and enhanced accuracy. The Lancets segment contributes significantly but shows lower growth than others segments. Geographically, the market is concentrated in urban areas with better access to healthcare facilities and higher diabetes prevalence.
France Self-Monitoring Blood Glucose Devices Market Product Innovations
Recent innovations in the France Self-Monitoring Blood Glucose Devices market focus on improving accuracy, ease of use, and connectivity. Miniaturization, wireless connectivity (Bluetooth), and integration with smartphone apps are key trends. These innovations enhance patient compliance by providing real-time data, remote monitoring capabilities, and seamless data integration with other healthcare apps. Such developments enhance patient engagement and improve the management of diabetes.
Report Scope & Segmentation Analysis
This report segments the France Self-Monitoring Blood Glucose Devices market by component:
Glucometer Devices: This segment is expected to experience a CAGR of xx% during the forecast period, driven by the rising demand for advanced features and improved accuracy. The competitive landscape is highly dynamic with both established and emerging players vying for market share.
Test Strips: This segment holds the largest market share and is anticipated to continue its growth trajectory, driven by the continuous need for replacement strips. Competitive dynamics are based on price and accuracy, with technological advancements continuously improving the overall user experience.
Lancets: This segment witnesses consistent demand with projected growth at a CAGR of xx%. Competition is moderate among players specializing in the production of lancets.
Key Drivers of France Self-Monitoring Blood Glucose Devices Market Growth
Several factors propel the growth of the France Self-Monitoring Blood Glucose Devices market. These include:
- Rising Prevalence of Diabetes: The increasing number of people diagnosed with diabetes in France is a major driver.
- Technological Advancements: Innovations like wireless connectivity and mobile app integration improve patient adherence.
- Government Initiatives: Policies promoting diabetes management and supporting healthcare access play a role.
- Growing Awareness: Increased public awareness about diabetes and self-monitoring is crucial for market growth.
Challenges in the France Self-Monitoring Blood Glucose Devices Market Sector
The France Self-Monitoring Blood Glucose Devices market faces challenges, including:
- High Cost of Devices and Consumables: This creates affordability issues for some patients.
- Regulatory Hurdles: Stricter regulations can slow down product approvals and market entry.
- Intense Competition: The market is quite competitive which may affect profitability for some players.
Emerging Opportunities in France Self-Monitoring Blood Glucose Devices Market
Opportunities exist in areas such as:
- Integration with Telehealth Platforms: Expanding remote patient monitoring and virtual care services.
- Development of AI-powered Devices: Enhancing diagnostics and data interpretation capabilities.
- Focus on Personalized Medicine: Tailoring devices and treatments to individual needs.
Leading Players in the France Self-Monitoring Blood Glucose Devices Market Market
- Arkray Inc
- Roche Diabetes Care
- Rossmax International Ltd
- Bionime Corporation
- Abbott Diabetes Care
- VivaChek
- LifeScan
- Menarini
- Ascensia Diabetes Care
Key Developments in France Self-Monitoring Blood Glucose Devices Market Industry
January 2023: LifeScan published results from a real-world data analysis of over 144,000 people with diabetes, demonstrating improved glycemic control using a Bluetooth-connected blood glucose meter and a mobile app. This highlights the growing importance of digital health integration.
January 2022: Roche launched the Cobas Pulse point-of-care blood glucose monitor for hospital professionals, featuring a touchscreen smartphone-like companion device. This signifies advancements in hospital-based glucose monitoring technology.
Future Outlook for France Self-Monitoring Blood Glucose Devices Market Market
The future of the France Self-Monitoring Blood Glucose Devices market looks promising. Continuous technological innovation, rising diabetes prevalence, and growing government support will drive market expansion. Strategic collaborations, product diversification, and focus on personalized solutions will be crucial for players to thrive in this dynamic market. The market is expected to continue its growth trajectory, driven by these factors and the increasing integration of digital health technologies.
France Self-Monitoring Blood Glucose Devices Market Segmentation
-
1. Component
- 1.1. Glucometer Devices
- 1.2. Test Strips
- 1.3. Lancets
France Self-Monitoring Blood Glucose Devices Market Segmentation By Geography
- 1. France

France Self-Monitoring Blood Glucose Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 7.18% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Rising Diabetes Prevalence in France
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. France Self-Monitoring Blood Glucose Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Component
- 5.1.1. Glucometer Devices
- 5.1.2. Test Strips
- 5.1.3. Lancets
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. France
- 5.1. Market Analysis, Insights and Forecast - by Component
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Arkray Inc *List Not Exhaustive 7 2 COMPANY SHARE ANALYSI
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Roche Diabetes Care
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Rossmax International Ltd
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Bionime Corporation
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Abbott Diabetes Care
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 VivaChek
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 LifeScan
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Menarini
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Ascensia Diabetes Care
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 Arkray Inc *List Not Exhaustive 7 2 COMPANY SHARE ANALYSI
List of Figures
- Figure 1: France Self-Monitoring Blood Glucose Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: France Self-Monitoring Blood Glucose Devices Market Share (%) by Company 2024
List of Tables
- Table 1: France Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: France Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Component 2019 & 2032
- Table 3: France Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 4: France Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Component 2019 & 2032
- Table 5: France Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the France Self-Monitoring Blood Glucose Devices Market?
The projected CAGR is approximately 7.18%.
2. Which companies are prominent players in the France Self-Monitoring Blood Glucose Devices Market?
Key companies in the market include Arkray Inc *List Not Exhaustive 7 2 COMPANY SHARE ANALYSI, Roche Diabetes Care, Rossmax International Ltd, Bionime Corporation, Abbott Diabetes Care, VivaChek, LifeScan, Menarini, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Ascensia Diabetes Care.
3. What are the main segments of the France Self-Monitoring Blood Glucose Devices Market?
The market segments include Component.
4. Can you provide details about the market size?
The market size is estimated to be USD 532 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Rising Diabetes Prevalence in France.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes-one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "France Self-Monitoring Blood Glucose Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the France Self-Monitoring Blood Glucose Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the France Self-Monitoring Blood Glucose Devices Market?
To stay informed about further developments, trends, and reports in the France Self-Monitoring Blood Glucose Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence